N-Boc-L-tert-Leucine CAS:62965-35-9

Mumakemikari echisikigo, N-Boc-L-tert-Leucine inoshanda sechishandiso chakakosha chekubatanidza zvakasara zveL-tert-Leucine muzvimiro zvepeptide. Boka rayo remaamino rakachengetedzwa neBoc rinobvumira kuumbwa kwepeptide bond yakadzorwa uye kuunganidzwa kweamino acids panguva yekugadzira peptide yakasimba. Nekushandisa N-Boc-L-tert-Leucine sechinhu chakakosha, vaongorori vanogona kugadzirisa hunhu nemabasa emapeptide mukutsvaga mishonga, zvidzidzo zvebiochemical, uye sainzi yezvinhu. Musanganiswa uyu unowana mashandisirwo mu peptide chemistry nekugadzirwa kwemishonga, uko kunoita basa rakakosha mukugadzira mamorekuru epeptidic ane mabasa chaiwo uye zvinangwa zvebiological. N-Boc-L-tert-Leucine inogonesa kushandurwa kwe peptide backbones, side chains, uye stereochemistry kuti iwedzere bioavailability, kugadzikana, uye receptor binding affinity ye peptide-based therapeutics. Kushandiswa kwayo mu peptide engineering kunobvumira kugadzirwa kwezvimiro zvitsva zvepeptide zvine pharmacological profiles dzakavandudzwa uye therapy potential. Muindasitiri yemishonga, N-Boc-L-tert-Leucine inoshandiswa mukugadzira mishonga yepeptide, peptide conjugates, uye peptidomimetics ine mabasa akasiyana-siyana ehupenyu. Kushandiswa kwayo kunosvika pakugadzira mishonga yekudzivirira peptide, enzyme inhibitors, uye receptor ligands kune dzakasiyana siyana zvirwere. Nekubatanidza N-Boc-L-tert-Leucine muzvikamu zvepeptide, masayendisiti anogona kushandisa chimiro chayo kugadzira mapeptides zvine simba rakawedzerwa, kusarudza, uye kugadzikana, zvichigadzira nzira yekuwana mishonga mitsva uye nzira dzekurapa munzvimbo dzakadai sekenza, immunology, uye metabolic disorders.